NCT05106530Unknown不适用
Arrhythmogenic Risk Assessment in Coronary Artery Ectasia Patients
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 90
- 试验地点
- 1
- 主要终点
- Precence of arrhythmias in 24 hours Holter monitoring
研究概览
简要总结
The investigators thought to explore arrhythmias outcome - hidden arrhythmias, ECG features: Tp-Te interval and Tp-Te/QTc ratio, fQRS among patients with coronary artery ectasia as compared to normal coronary artery patients.
详细描述
All patients will be subjected to:
A. Full history taking:
- Including age, sex, history of DM, HTN, dyslipidemia and Body surface area.
B. Holter monitoring for 24 hours:
- Heart rate variability
- Hidden arrhythmias
- Hidden ischemia by monitoring ST segment changes
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Other
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Subjects with suspected CAD who are referred for elective coronary angiography and/or interventions
排除标准
- •Patients with a history of cardiomyopathy and myocardial infarction (MI), left ventricular hypertrophy (LVH), pathological Q wave on ECG, typical left bundle block or right bundle block, incomplete right bundle block, or paced rhythm on ECG.
- •Patients with severe renal impairment
- •Post CABG patients
- •Patients of acute coronary syndrome
结局指标
主要结局
Precence of arrhythmias in 24 hours Holter monitoring
时间窗: 1 year
Incidence of arrhythmias in Holter monitoring among coronary artery ectasia patients as compared to normal coronary artery patients.
次要结局
- • Heart rate variability in Holter monitoring(1 year)
- • Silent ischemia as detected by Holter(1 years)
研究者
Mark Mohsen Nady Kamel
Resident at Cardiology Department
Assiut University
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Cardiomyopathy Arrhythmia Risk EvaluationCardiomyopathyNCT02560844University Health Network, Toronto164
已完成
不适用
Changes in Heart Rhythms Associated With Antipsychotic Drug TreatmentSchizophreniaBipolar DisorderSchizoaffective DisorderNCT00538122Vanderbilt University12
已完成
不适用
Innovative Stratification of Arrhythmic Risk (ISAR-Trial): ElderyMyocardial InfarctionNCT00196300Deutsches Herzzentrum Muenchen500
Unknown
不适用
ARrhythmias in MYocarditisEndomyocardial BiopsyArrythmiaBiomarkerHeart FailureMyocarditisCardiomyopathySudden Cardiac DeathNCT03801681Medical University of Warsaw100
已完成
不适用
Cardiovascular Events in Chronic Obstructive Pulmonary Disease Patients Initiating Olodaterol or Other Long-acting beta2 AgonistsPulmonary Disease, Chronic ObstructiveNCT03405363Boehringer Ingelheim65,406